当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 利润表

海翔药业

(002099)

  

流通市值:94.68亿  总市值:94.86亿
流通股本:16.16亿   总股本:16.19亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入925,159,120.06486,432,558.841,938,465,657.861,444,477,964.62
  营业收入925,159,120.06486,432,558.841,938,465,657.861,444,477,964.62
二、营业总成本892,850,523.47466,678,445.961,859,241,448.521,375,713,221.67
  营业成本683,418,968.06364,118,695.461,420,156,018.711,049,648,513.54
  税金及附加16,850,848.628,884,372.0728,993,591.1419,640,680.13
  销售费用9,629,893.032,712,154.2533,253,110.9722,610,881.65
  管理费用133,331,324.7469,258,774.44307,458,090.96211,600,191.98
  研发费用61,498,851.3330,648,501.47129,445,758.1497,696,518.45
  财务费用-11,879,362.31-8,944,051.73-60,065,121.4-25,483,564.08
  其中:利息费用15,041,971.598,043,340.6828,797,382.5522,976,121.9
  其中:利息收入25,536,249.5312,026,051.755,849,902.6444,523,751.07
三、其他经营收益
  加:公允价值变动收益6,903,972.573,050,776.04-16,490,493.01336,069.83
  加:投资收益-3,170,711.711,846,487.168,783,002.766,755,798.04
  资产处置收益-26,079.94-98,061.311,037,057.82547,933.61
  资产减值损失(新)-21,385,830.75-11,568,766.81-425,167,031.6-93,574,540.94
  信用减值损失(新)-1,317,707.28-2,502,471.14-4,543,717.643,214,636.33
  其他收益11,468,536.325,516,173.2521,013,646.4115,670,918.24
四、营业利润24,780,775.815,998,250.07-336,143,325.921,715,558.06
  加:营业外收入2,009,256.5704,108.512,751,267.62,047,127.06
  减:营业外支出7,494,738.24,103,343.93,489,171.95675,883.68
五、利润总额19,295,294.112,599,014.68-336,881,230.273,086,801.44
  减:所得税费用6,672,088.174,285,579.56-2,993,768.36-7,147,511.18
六、净利润12,623,205.938,313,435.12-333,887,461.9110,234,312.62
(一)按经营持续性分类
  持续经营净利润12,623,205.938,313,435.12-333,887,461.9110,234,312.62
(二)按所有权归属分类
  归属于母公司股东的净利润14,093,711.99,229,942.41-330,267,195.3711,979,756.66
  少数股东损益-1,470,505.97-916,507.29-3,620,266.54-1,745,444.04
  扣除非经常损益后的净利润19,283,282.226,514,633.64-340,270,999.7518,389,225.63
七、每股收益
  (一)基本每股收益0.010.01-0.210.01
  (二)稀释每股收益0.010.01-0.210.01
八、其他综合收益--3,828,942.94-
  归属于母公司股东的其他综合收益--3,828,942.94-
九、综合收益总额12,623,205.938,313,435.12-330,058,518.9710,234,312.62
  归属于母公司股东的综合收益总额14,093,711.99,229,942.41-326,438,252.4311,979,756.66
  归属于少数股东的综合收益总额-1,470,505.97-916,507.29-3,620,266.54-1,745,444.04
公告日期2025-08-302025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑